Osimertinib is a member of the class of aminopyrimidines that is 4-(1-methylindol-3-yl)pyrimidin-2-amine in which one of the amino hydrogens is replaced by a 2-methoxy-4-[2-(dimethylamino)ethyl](methyl)amino-5-acrylamidophenyl group. Used (as the mesylate salt) for treatment of EGFR T790M mutation positive non-small cell lung cancer. Among its listed roles, it functions as a antineoplastic agent and an epidermal growth factor receptor antagonist. It belongs to the class of indoles, an aminopyrimidine, a biaryl, a secondary amino compound, a tertiary amino compound, a monomethoxybenzene, a member of acrylamides, a substituted aniline and a secondary carboxamide. It is the conjugate base of osimertinib(1+). It is grouped under the following drug class(es): Antineoplastic agents, Kinase inhibitors and QTc-prolonging agents. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mereletinib, osimertinibum and AZD-9291. Its PubChem CID is 71496458.
Osimertinib
| CAS No | 1421373-65-0 |
|---|---|
| Molecular Formula | C28H33N7O2 |
| Molecular Weight | 499.6 g/mol |
| Synonyms | N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Osimertinib is a member of the class of aminopyrimidines that is 4-(1-methylindol-3-yl)pyrimidin-2-amine in which one of the amino hydrogens is replaced by a 2-methoxy-4-[2-(dimethylamino)ethyl](methyl)amino-5-acrylamidophenyl group.
The listed CAS number is 1421373-65-0.
The listed molecular formula is C28H33N7O2.
The listed molecular weight is 499.6 g/mol.
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide.
The source lists Mereletinib, osimertinibum and AZD-9291.